[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360180-105":59,"doc-detail-360180-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-npsr1-mediated-hippo-yap1-dysregulation-suppresses-gastric-cancer-progression","Targeting NPSR1-mediated Hippo-YAP1 dysregulation suppresses gastric cancer progression","","Targeting G protein-coupled receptors (GPCRs) has become a promising strategy for cancer therapy, while Hippo pathway inactivation is recognized as a key driver of gastric cancer progression. The molecular basis of GPCR–Hippo cross-talk remains unclear. This work identifies NPSR1 as an oncogenic driver, showing NPSR1 overexpression in gastric cancer tissues and a negative correlation with patient prognosis. NPSR1 promotes proliferation and migration, and silencing suppresses tumor progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-npsr1-mediated-hippo-yap1-dysregulation-suppresses-gastric-cancer-progression/360180/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-npsr1-mediated-hippo-yap1-dysregulation-suppresses-gastric-cancer-progression/360180.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research focus of this study?","Question",{"text":112,"@type":113},"The study investigates how NPSR1-mediated dysregulation affects Hippo signaling through YAP1, and how this suppression influences gastric cancer progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does NPSR1 affect gastric cancer progression according to the findings?",{"text":117,"@type":113},"NPSR1 overexpression accelerates gastric cancer cell proliferation and migration in both in vivo and in vitro models, while NPSR1 silencing suppresses tumor progression.",{"name":119,"@type":110,"acceptedAnswer":120},"Through which molecular mechanisms does NPSR1 regulate YAP1?",{"text":121,"@type":113},"NPSR1 activates the cAMP/CREB pathway to enhance YAP1 transcription and also facilitates PP2Ac expression to reduce YAP1 phosphorylation, promoting YAP1 nuclear translocation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360180,1790192791,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cellular and Molecular Life Sciences (2026) 83:217  \n[https://doi.org/10.1007/s00018-026-06181-6](https://doi.org/10.1007/s00018-026-06181-6) Cellular and Molecular Life Sciences  \nORIGINAL ARTICLE  \nTargeting NPSR1-mediated Hippo-YAP1 dysregulation suppresses gastric cancer progression  \nWenjing Qin1 · Mei Ma2 · Weidan Fang2 · Xian Wang2 · Bin Yu1  \nReceived: 13 August 2025 / Revised: 4 December 2025 / Accepted: 18 December 2025 © The Author(s) 2026  \nAbstract  \nThe targeting of G protein-coupled receptors (GPCRs) has emerged as a promising strategy for developing novel cancer therapies. Moreover, inactivation of the Hippo signaling pathway is recognized as a critical driver of gastric cancer (GC) progression. However, the precise molecular mechanisms underlying cross-talk between GPCRs and the Hippo pathway remain to be further investigated. Here, we identify NPSR1 as an oncogenic driver promoting GC advancement. NPSR1 is significantly overexpressed in GC tissues and negatively correlates with patient prognosis. Both in vivo and in vitro studies demonstrated that NPSR1 overexpression robustly accelerated GC cell proliferation and migration, while its silencing suppressed tumor progression. Mechanistically, our findings revealed a dual regulatory axis: (i) NPSR1 activated the cAMP/ CREB pathway to enhance YAP1 transcription; and (ii) it directly facilitated phosphatase PP2Ac expression, thereby reducing YAP1 phosphorylation. This promotes the translocation of YAP1 from the cytoplasm to the nucleus, enhancing its oncogenic function. Our study uncovers a novel molecular link between NPSR1 hyperactivation and Hippo pathway suppression through coordinated transcriptional upregulation and post-translational modulation of YAP1 . These results highlight NPSR1 as a potential therapeutic target for GC, offering a rationale for developing targeted inhibitors to restore Hippo signaling.  \nKeywords Gastric cancer · NPSR1/ GPR154 · YAP1 · PP2A · cAMP/CREB  \nAbbreviations  \nGC Gastric cancer  \nGPCRs G protein-coupled receptors  \nGPR154 G protein-coupled receptor 154  \nNPSR1 Neuropeptide S receptor1  \nNPS Neuropeptide S  \nTCGA The Cancer Genome Atlas OS Overall survival  \ncAMP Cyclic adenosine monophosphate CREB cAMP-responsive element binding protein PP2A Protein phosphatase 2 A  \nPP2Ac Protein Phosphatase 2 Catalytic Subunit Alpha PPP2CA  \nWenjing Qin and Mei Ma contributed equally to this work.  \n􀀍 Bin Yu[yubin@ncu.edu.cn](yubin@ncu.edu.cn)  \n1 Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, PR China  \n2 Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, PR China  \nIntroduction  \nGastric cancer (GC) currently ranks as the fifth most prevalent malignancy worldwide and is the third leading cause of cancer-associated mortality, imposing a significant public health burden [1] . Epidemiological data indicate over one million new cases are diagnosed annually, with an alarming rise in GC incidence among younger populations under 50 years of age. It is important to note that the disease is frequently diagnosed at an advanced stage, in spite of recent advancements in early identification and cancer sensitivity screening, resulting in 768,000 deaths globally in 2020 [2] . The limited efficacy of current therapeutic approaches underscores an urgent need to elucidate the molecular mechanisms driving GC progression and to develop targeted intervention strategies.  \nG protein-coupled receptors (GPCRs), predominantly localized on the cell membrane, serve as pivotal mediators in signal transduction, orchestrating diverse cellular physiological and pathological processes. These receptors are structurally characterized by their distinctive seven transmembrane helical domains [3] . Upon ligand binding, GPCRs undergo  \n1 3  \nconformational changes that facilitate the release of intracellularly bound heterotrimeric G","cbCaihn6G8HHupQ6","https://ap.wps.com/l/cbCaihn6G8HHupQ6","pdf",11000853,17,"English","# Abstract\n# Introduction\n## Gastric cancer epidemiology and unmet therapeutic needs\n## GPCRs in cancer signaling\n## Hippo signaling and its role in gastric cancer","[{\"question\":\"What is the main research focus of this study?\",\"answer\":\"The study investigates how NPSR1-mediated dysregulation affects Hippo signaling through YAP1, and how this suppression influences gastric cancer progression.\"},{\"question\":\"How does NPSR1 affect gastric cancer progression according to the findings?\",\"answer\":\"NPSR1 overexpression accelerates gastric cancer cell proliferation and migration in both in vivo and in vitro models, while NPSR1 silencing suppresses tumor progression.\"},{\"question\":\"Through which molecular mechanisms does NPSR1 regulate YAP1?\",\"answer\":\"NPSR1 activates the cAMP/CREB pathway to enhance YAP1 transcription and also facilitates PP2Ac expression to reduce YAP1 phosphorylation, promoting YAP1 nuclear translocation.\"}]","Targeting NPSR1-mediated Hippo-YAP1 dysregulation suppresses gastric cancer progression | PDF",1790138989,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85bac6a283c3fdcc6feef0b85984907a.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d00fe72170fb66ba407c90a754bfdbe1.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ec7f06e26ce309f67becc0c44531ea0.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d35f884f1d1ba0cff4c99524947e037.webp",980,1301]